← All candidates
Four insider buys in the last year — $1.99M in all.
Gilbert Ray Cisneros, Jr.Small Business · Armed Servicestraded 18 Aug · filed 10 Sep · selfBought$1K–$15Kself18 Aug30d ago10 Sep7d ago78 filings on record.
PODDINSULET CORP
NasdaqGS · Healthcare · $9.75B
$140.60
+0.98% today
Four insider buys in the last year — $1.99M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 4 buys● 1 sell◆ 8 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$9.75B
Float
69.1M
100% public
Short % float
Pro
Price / profit
26.4
Price / future profit
18.2
Price / sales
3.2
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
President and CEO
McEvoy Ashley
Bought $1.03M on Feb 20 — 4,300 sh @ $239.35, held direct, 31% of their stake.
0 of 1 position beat the S&P
Director
Minogue Michael R
Bought $499.8K on Feb 25 — 2,030 sh @ $246.23, held indirect, 12% of their stake.
0 of 1 position beat the S&P
Director
Stonesifer Timothy C.
Bought $299.9K on Dec 5 — 962 sh @ $311.73, held direct, 21% of their stake.
0 of 1 position beat the S&P
Congress
▸ Disclosures lag trades by 30–45 days.
1 disclosure12 mo
MemberTradeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
73 more transactions on Pro →Context
Wall St
$242.43 avg target
+72.4% vs today · 23 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$1.42 act+$0.23
Q4 '25$1.55 act+$0.09
Q3 '25$1.24 act+$0.09
Q2 '25$1.17 act+$0.25
Coverage
Insulet (PODD) Announces Positive Clinical Trial Results for Next-Generation Omnipod 6 AID SystemInsider Monkey · 06-19Insulet Corporation Stock: Is PODD Underperforming the Healthcare Sector?Barchart · 06-19Is Insulet Corporation (PODD) A Good Stock To Buy Now?Insider Monkey · 06-11Assessing Insulet (PODD) Valuation After New Omnipod Clinical Data And System UpdatesSimply Wall St. · 06-11
The file stays open
78 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice